BBHvsFTXHETF Comparison
VS
VanEck Biotech ETF (BBH) and First Trust Nasdaq Pharmaceuticals ETF (FTXH) belong to the same industry segment: US Health Care. Both ETFs have the same top 1 sector exposures: Healthcare. BBH is less expensive with a Total Expense Ratio (TER) of 0.35%, versus 0.6% for FTXH. BBH is up 11.26% year-to-date (YTD) with -$7M in YTD flows. FTXH performs better with 19.95% YTD performance, and +$911M in YTD flows. Run a side-by-side ETF comparison of BBH and FTXH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
BBH vs FTXH performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 08/05/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | BBH FTXH | +0.13%+1.26% | +12.94%+15.65% | +11.26%+19.95% | +31.17%+50.32% | +34.53%+55.55% | -1.53%+57.15% |
| Flows | BBH FTXH | -+$901M | -$63K+$901M | -$7M+$911M | -$28M+$914M | -$180M+$906M | -$139M+$906M |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | BBH FTXH | +21.11%+18.17% | +19.38%+16.95% | +19.26%+16.63% | +21.51%+16.11% |
| Max drawdown | BBH FTXH | -5.29%-4.43% | -10.54%-7.50% | -22.78%-19.32% | -39.88%-19.32% |
| Max drawdown duration | BBH FTXH | 29d20d | 150d99d | 440d393d | 1822d393d |
Trading data
BBH | FTXH | |
Last sale 8/6/2026 at 1:30 PM | $210.44 | $39.11 |
| Previous close 08/05/2026 | $210.49 | $39.40 |
| Consolidated volume 08/05/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of July 31, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
BBH | FTXH | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 8/6/2026 at 1:30 PM
Live
Closed
BBH | FTXH | |
|---|---|---|
| Last price | $210.44 | $39.11 |
| 1D performance | -0.03% | -0.74% |
| AuM | $409.71 M | $948.00 M |
| E/R | 0.35% | 0.6% |
Characteristics
BBH | FTXH | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | VanEck | First Trust |
| Benchmark | MVIS US Listed Biotech 25 Index | NASDAQ US Smart Pharmaceuticals Index |
| N° of holdings | 24 | 50 |
| Asset class | Equities | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | December 20, 2011 | September 20, 2016 |
| ESG | No | No |
Advertisement
Exposure
Countries
BBH
USA
87.33%
Other
12.67%
FTXH
USA
95.49%
Other
4.51%
Sectors
BBH
Healthcare
100%
FTXH
Healthcare
99.86%
Other
0.14%
Advertisement
Diversification
BBH
Total weight of top 15 holdings out of 15
85.08%
FTXH
Total weight of top 15 holdings out of 15
66.57%
Top 15 holdings
Data as of June 30, 2026
BBH
Amgen, Inc.
15.15%
Gilead Sciences, Inc.
12.75%
Vertex Pharmaceuticals, Inc.
9.15%
Regeneron Pharmaceuticals, Inc.
6.26%
Revolution Medicines, Inc.
5.41%
Natera, Inc.
4.92%
argenx SE
4.88%
IQVIA Holdings, Inc.
4.30%
Alnylam Pharmaceuticals, Inc.
3.73%
Biogen, Inc.
3.63%
Moderna, Inc.
3.34%
Illumina, Inc.
3.26%
BeOne Medicines Ltd.
2.85%
United Therapeutics Corp.
2.84%
Insmed, Inc.
2.62%
FTXH
Eli Lilly & Co.
7.74%
AbbVie, Inc.
7.39%
Johnson & Johnson
6.98%
Merck & Co., Inc.
6.92%
Bristol Myers Squibb Co.
6.18%
Biogen, Inc.
3.73%
Viatris, Inc.
3.70%
Cardinal Health, Inc.
3.54%
Vertex Pharmaceuticals, Inc.
3.42%
Amgen, Inc.
3.18%
Pfizer Inc.
2.95%
Gilead Sciences, Inc.
2.89%
United Therapeutics Corp.
2.76%
Regeneron Pharmaceuticals, Inc.
2.73%
Jazz Pharmaceuticals Plc
2.46%
Frequently asked questions about BBH and FTXH
How have the BBH and FTXH ETFs performed in 2026?
As of August 5, 2026, BBH is up 11.26% year-to-date (YTD), while FTXH has returned 19.95%. That puts FTXH better performer ahead so far this year.
Which ETF is attracting more investor money: BBH or FTXH?
Year-to-date, the BBH ETF saw -$7M in flows, compared to +$911M for FTXH.
Which ETF is more volatile: BBH or FTXH?
Over the past year, BBH had a volatility of 19.38%, while FTXH experienced 16.95%.
Which ETF is bigger: BBH or FTXH?
As of August 5, 2026, BBH holds $409.71 M in assets under management (AUM), while FTXH manages $948.00 M.
What sectors do the BBH and FTXH ETFs invest in?
BBH leans toward sectors like Healthcare. Meanwhile, FTXH focuses on Healthcare.
What are the top holdings of the BBH ETF and FTXH ETF?
BBH top holdings include Amgen, Inc., Gilead Sciences, Inc. and Vertex Pharmaceuticals, Inc.. FTXH holds in its top three: Eli Lilly & Co., AbbVie, Inc. and Johnson & Johnson.
Which ETF is more diversified: BBH or FTXH?
BBH holds 24 securities with 85.08% of its assets in the top 15. FTXH has 50 securities and a top 15 weight of 66.57%.
Advertisement
Advertisement
